# Contact Vyra Peptides — Editorial Desk

> Reach the Vyra Peptides editorial desk regarding citations, corrections, or research-related correspondence about our metabolic peptide digest.

Correspondence on citations, corrections, and research-related questions — the feedback a data-forward desk most wants to receive.

## Editorial correspondence

Vyra Peptides welcomes correspondence about the research record: a citation quoted inaccurately, an effect size or confidence interval that has been corrected in an erratum, a regulatory status that has changed (for example, if retatrutide achieves approval or WADA classification), or a peer-reviewed study on tesamorelin or retatrutide that should be added to the [references page](/references).

Corrections that improve accuracy are the most useful messages this desk receives. The most actionable notes specify the page, the exact passage in question, and a supporting DOI or PubMed ID. That allows verification against the primary source quickly.

**Editorial mailbox:** editors@vyrapeptides.com

## What this desk cannot do

Several things fall outside what this site can address — not out of indifference, but because they fall outside what a literature digest is:

- Advise on, recommend, or comment on human use of tesamorelin or retatrutide for any purpose.
- Suggest a dose, schedule, reconstitution method, or administration route for any individual.
- Diagnose a condition or assess whether a research finding applies to a particular person's situation.
- Sell, source, recommend, or help locate either compound from any supplier or vendor.
- Comment on gray-market retatrutide suppliers, vendors, or products.
- Advise athletes on anti-doping compliance, given that tesamorelin is WADA-prohibited.

Readers seeking clinical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored on a non-urgent schedule.

---

A data-forward literature digest — effect sizes and citations, not recommendations, and nothing for sale.
